Are Soluble Receptors of Advanced Glycation End Products Associated with Pre-clinical Diastolic Dysfunction in Patients with Diabetes?

被引:0
|
作者
Lancefield, Terase F. [1 ]
Wai, Bryan [1 ]
Patel, Sheila K. [1 ]
Velkoska, Elena [1 ]
Ord, Michelle [2 ]
Srivastava, Piyush M. [2 ]
Burrell, Louise M. [1 ]
机构
[1] Univ Melbourne, Dept Med, Austin Hlth, Heidelberg, Vic, Australia
[2] Austin Hlth, Dept Cardiol, Heidelberg, Vic, Australia
关键词
Diastolic function; Biomarkers; Type; 2; Diabetes;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
18356
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Left ventricular diastolic function is associated with serum levels of advanced glycation end products in IDDM patients
    Berg, TJ
    Snorgaard, O
    Hildebrandt, P
    Faber, J
    Torjesen, PA
    Hanssen, KF
    DIABETOLOGIA, 1998, 41 : A28 - A28
  • [22] ADVANCED GLYCATION END PRODUCTS, SOLUBLE RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS AND RISK OF LIVER CANCER.
    Moy, K. A.
    Jiao, L.
    Freedman, N. D.
    Weinstein, S. J.
    Sinha, R.
    Virtamo, J.
    Albanes, D.
    Stolzenberg-Solomon, R. Z.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 175 : S103 - S103
  • [23] Skin autofluorescence (a marker for advanced glycation end products) and erectile dysfunction in diabetes
    Kouidrat, Youssef
    Zaitouni, Ahmad
    Amad, Ali
    Diouf, Momar
    Desailloud, Rachel
    Loas, Gwenole
    Lalau, Jean-Daniel
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (01) : 108 - 113
  • [24] Advanced glycation end products are associated with immature angiogenesis and peritoneal dysfunction in patients on peritoneal dialysis
    Nakano, Toshiaki
    Mizumasa, Tohru
    Kuroki, Yusuke
    Eriguchi, Masahiro
    Yoshida, Hisako
    Taniguchi, Masatomo
    Masutani, Kosuke
    Tsuruya, Kazuhiko
    Kitazono, Takanari
    PERITONEAL DIALYSIS INTERNATIONAL, 2020, 40 (01): : 67 - 75
  • [25] Adrenomedullin Helps Risk Stratify Patients With Pre-Clinical Diastolic Dysfunction
    Egnatios, Jeremy
    Marston, Nick
    Arbit, Boris
    Lee, Elizabeth
    Aramin, Hermineh
    Struck, Joachim
    Maisel, Alan S.
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (08) : S26 - S26
  • [26] ADVANCED GLYCATION END PRODUCTS AND THE SOLUBLE FORM OF THE AGE RECEPTOR IN PATIENTS WITH TYPE II DIABETES AND OSTEOARTHRITIS
    Thauerer, B.
    Kullich, W.
    Stritzinger, B.
    Kroell-Kalbhenn, A.
    Reimair, S.
    Salzer, A.
    Steinecker-Frohnwieser, B.
    OSTEOARTHRITIS AND CARTILAGE, 2022, 30 : S393 - S394
  • [27] METHODICAL VALIDATION OF AN IMMUNOASSAY FOR THE DETERMINATION OF SOLUBLE RECEPTORS OF ADVANCED GLYCATION END PRODUCTS (SRAGE)
    Wittwer, Christin
    Lehner, J.
    Fersching, D.
    Siegele, B.
    Holdenrieder, S.
    TUMOR BIOLOGY, 2010, 31 : S75 - S76
  • [28] Advanced glycation end products, diabetes and ageing
    Nass, N.
    Bartling, B.
    Santos, A. Navarrete
    Scheubel, R. J.
    Boergermann, J.
    Silber, R. E.
    Simm, A.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2007, 40 (05): : 349 - 356
  • [29] Advanced glycation end products, diabetes, and the brain
    Coker, Laura H.
    Wagenknecht, Lynne E.
    NEUROLOGY, 2011, 77 (14) : 1326 - 1327
  • [30] Advanced glycation end products, dementia, and diabetes
    Lovestone, Simon
    Smith, Ulf
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (13) : 4743 - 4744